|
|
 |
|
Viewing report
|
|
|
|
The Future of Cox-ii Inhibitors: Market Challenges and Pipeline Initiatives
Datamonitor, Oct 2003, Pages: 32
Introduction:
The non-steroidal anti-inflammatory drug (Nsaid) market has been dominated by Cox-ii inhibitors for the past several years, but the majority of the success of these products has occurred in the US. This Market Brief analyzes the challenges facing Cox-ii inhibitors in Europe, as well as the keys to success for these products upon launch in Japan in 2004. Finally, the Brief evaluates novel compounds and mechanisms with the potential to directly challenge Cox-ii inhibitors in the future.
Scope:
* Analysis highlights barriers to success for Cox-ii inhibitor sales in Europe, including regulatory issues, cost constraints, and clinical uncertainty
* Evaluation of the current demand for Cox-ii inhibitors in Japan, where the products are not yet approved
* Outlines the difficulties that companies will face in penetrating the Japanese market upon approval
* Analysis of three novel mechanisms of action with the potential to compete directly with Cox-ii inhibitors
Report Highlights:
To date, the European market has been a commercial disappointment for the Cox-ii inhibitors pharmaceutical companies must tailor their expectations and marketing strategies to this market
Cox-ii inhibitors will finally be launched to the Japanese market, but specific challenges await interested players
Novel challengers to the established Cox-ii inhibitors are on the way, but require further differentiation for market success
Reasons to Purchase:
* Understand the factors that have held back the success of Cox-ii inhibitors in Europe
* Identify the hurdles awaiting entrants to the Japanese Cox-ii inhibitor market, and the strategies required for success
* Analyze the next wave of products with the potential to make a big splash in the Nsaid market, for competitive intelligence or potential licensing
Customers who bought this item also bought
Cox-ii Inhibitors: Comparison of Global Markets and Factors Influencing Performance
Market Dynamics 2002: Anti-Cancer Innovatives Series Part II - Angiogenesis Inhibitors
The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran
The 2009 Import and Export Market for Butadiene Rubber (BR) in Belarus
The 2009 Import and Export Market for Butadiene Rubber (BR) in Bulgaria
The 2009 Import and Export Market for Butadiene Rubber (BR) in Slovakia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Turkey
The 2009 Import and Export Market for Butadiene Rubber (BR) in China
The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Estonia
The 2009 Import and Export Market for Butadiene Rubber (BR) in India
The 2009 World Market Forecasts for Imported Butadiene Rubber (BR)
|
|
|
|
